StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.09−0.15 (-11.74%)

Close on Nov 18, 2026Market cap $5.01MP/E –Yield –

Biomerica market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Biomerica's market cap was $6.94M on Nov 11, 2026, against $6.67M a year earlier. Over the last 5 years it ranged from $4.76M to $56.73M, with a median of $10.40M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.94M-2.1%
2025Dec 31, 2025$7.09M+40.5%
2024Dec 31, 2024$5.05M-76.0%
2023Dec 29, 2023$21.03M-53.2%
2022Dec 30, 2022$44.91M-7.7%
2021Dec 31, 2021$48.66M-16.9%
2020Dec 31, 2020$58.53M+98.1%
2019Dec 31, 2019$29.54M+94.1%
2018Dec 31, 2018$15.22M-52.2%
2017Dec 29, 2017$31.84M+69.4%
2016Dec 30, 2016$18.79M+92.1%
2015Dec 31, 2015$9.78M+45.6%
2014Dec 31, 2014$6.72M+18.4%
2013Dec 31, 2013$5.68M-2.8%
2012Dec 31, 2012$5.84M+77.1%
2011Dec 30, 2011$3.30M–

More Biomerica figures

See a number that looks wrong?